Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to -$8.9 million.

  • Sight Sciences' Free Cash Flow fell 295819.94% to -$8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.8 million, marking a year-over-year decrease of 2300.29%. This contributed to the annual value of -$22.7 million for FY2024, which is 5260.87% up from last year.
  • According to the latest figures from Q3 2025, Sight Sciences' Free Cash Flow is -$8.9 million, which was down 295819.94% from -$7.8 million recorded in Q2 2025.
  • Sight Sciences' Free Cash Flow's 5-year high stood at $311000.0 during Q3 2024, with a 5-year trough of -$22.2 million in Q1 2022.
  • Over the past 5 years, Sight Sciences' median Free Cash Flow value was -$11.6 million (recorded in 2025), while the average stood at -$12.1 million.
  • As far as peak fluctuations go, Sight Sciences' Free Cash Flow surged by 10306.95% in 2024, and later plummeted by 295819.94% in 2025.
  • Quarter analysis of 5 years shows Sight Sciences' Free Cash Flow stood at -$10.9 million in 2021, then tumbled by 43.68% to -$15.6 million in 2022, then soared by 56.83% to -$6.7 million in 2023, then surged by 46.71% to -$3.6 million in 2024, then plummeted by 147.19% to -$8.9 million in 2025.
  • Its Free Cash Flow stands at -$8.9 million for Q3 2025, versus -$7.8 million for Q2 2025 and -$11.6 million for Q1 2025.